Bayer is nearing the end of the road for glyphosate, executives say

Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.

Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.

More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.

Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.

Related Stories
“What we’re hoping to do is just help our farmers have one more tool that they can help protect their livestock...”
“We don’t need to mandate these on the highway.”
“We’re going to get this $280 million out to those Rio Grande Valley farmers and make sure they can see another day and farm another crop.”
“I can tell you that it is, in my estimation, a smart thing to do.”